150 related articles for article (PubMed ID: 32067504)
1. Non-invasive targeted iontophoretic delivery of cetuximab to skin.
Lapteva M; Sallam MA; Goyon A; Guillarme D; Veuthey JL; Kalia YN
Expert Opin Drug Deliv; 2020 Apr; 17(4):589-602. PubMed ID: 32067504
[No Abstract] [Full Text] [Related]
2. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
Dubey S; Kalia YN
J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
[TBL] [Abstract][Full Text] [Related]
3. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
[TBL] [Abstract][Full Text] [Related]
4. Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1.
Dubey S; Kalia YN
J Control Release; 2011 Jun; 152(3):356-62. PubMed ID: 21397646
[TBL] [Abstract][Full Text] [Related]
5. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
7. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection.
Petrilli R; Eloy JO; Saggioro FP; Chesca DL; de Souza MC; Dias MVS; daSilva LLP; Lee RJ; Lopez RFV
J Control Release; 2018 Aug; 283():151-162. PubMed ID: 29864476
[TBL] [Abstract][Full Text] [Related]
8. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor.
Dubey S; Perozzo R; Scapozza L; Kalia YN
Mol Pharm; 2011 Aug; 8(4):1322-31. PubMed ID: 21696184
[TBL] [Abstract][Full Text] [Related]
10. Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1b and a poly-Arg interferon beta-1b analogue.
Dubey S; Perozzo R; Scapozza L; Kalia YN
Int J Pharm; 2020 Nov; 589():119913. PubMed ID: 32971174
[TBL] [Abstract][Full Text] [Related]
11. In vitro optimization of dexamethasone phosphate delivery by iontophoresis.
Sylvestre JP; Guy RH; Delgado-Charro MB
Phys Ther; 2008 Oct; 88(10):1177-85. PubMed ID: 18719003
[TBL] [Abstract][Full Text] [Related]
12. Transdermal iontophoretic delivery of triptorelin in vitro.
Schuetz YB; Naik A; Guy RH; Vuaridel E; Kalia YN
J Pharm Sci; 2005 Oct; 94(10):2175-82. PubMed ID: 16136544
[TBL] [Abstract][Full Text] [Related]
13. Non-Invasive Delivery of Negatively Charged Nanobodies by Anodal Iontophoresis: When Electroosmosis Dominates Electromigration.
Sahraoui PF; Vadas O; Kalia YN
Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675200
[TBL] [Abstract][Full Text] [Related]
14. Transdermal iontophoretic delivery of vapreotide acetate across porcine skin in vitro.
Schuetz YB; Naik A; Guy RH; Vuaridel E; Kalia YN
Pharm Res; 2005 Aug; 22(8):1305-12. PubMed ID: 16078140
[TBL] [Abstract][Full Text] [Related]
15. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Mol Pharm; 2013 Nov; 10(11):4322-9. PubMed ID: 24028565
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic studies of the transdermal iontophoretic delivery of 5-OH-DPAT in vitro.
Ackaert OW; Van Smeden J; De Graan J; Dijkstra D; Danhof M; Bouwstra JA
J Pharm Sci; 2010 Jan; 99(1):275-85. PubMed ID: 19718740
[TBL] [Abstract][Full Text] [Related]
17. Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil.
Merino V; López A; Kalia YN; Guy RH
Pharm Res; 1999 May; 16(5):758-61. PubMed ID: 10350021
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: Targeted intraepidermal drug delivery.
Chen Y; Zahui T; Alberti I; Kalia YN
Eur J Pharm Biopharm; 2016 Feb; 99():94-102. PubMed ID: 26592154
[TBL] [Abstract][Full Text] [Related]
19. Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability.
Chen Y; Alberti I; Kalia YN
Eur J Pharm Biopharm; 2016 Feb; 99():103-13. PubMed ID: 26686649
[TBL] [Abstract][Full Text] [Related]
20. Iontophoretic transdermal delivery of haloperidol.
Alvarez-Figueroa MJ; Araya-Silva I; Díaz-Tobar C
Pharm Dev Technol; 2006; 11(3):371-5. PubMed ID: 16895847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
